MedTrace Logo

Study on the Burden of Influenza-related Hospitalizations and Emergency Room (ER) Visits in Children in Spain

NCT01592799 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 501

Last updated 2018-07-27

Study results available
· View outcomes & findings →

Summary

This study aims to quantify the inpatient and ER visits burden of laboratory-confirmed influenza, and compare the clinical features, severity, complications, risk factors and socioeconomic impact of influenza in children presenting with acute respiratory illness (ARI) and/or isolated fever, with or without laboratory-confirmed influenza.

Conditions

Interventions

PROCEDURE

Throat swab and/or nasopharyngeal swab

Samples will be tested to quantify the inpatient and ER visits burden of laboratory-confirmed influenza.

OTHER

Data collection

Log Sheet will be used to collected data on a monthly basis for the following age groups: \< 6 months; 6-23 months; 24-59 months; \> 5 years.

Sponsors & Collaborators

Principal Investigators

  • GSK Clinical Trials · GlaxoSmithKline

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Max Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-11-23
Primary Completion
2011-05-23
Completion
2011-05-23

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01592799 on ClinicalTrials.gov